Future forms of immunotherapy

Keyphrases

• Allergen Immunotherapy 100%
• Allergic Rhinitis 66%
• Treatment Options 33%
• Toll-like 33%
• Clinical Outcomes 33%
• Innate Immune Response 33%
• Immunological Response 33%
• Allergic Diseases 33%
• Standard of Care 33%
• Increased Safety 33%
• Receptor Agonist 33%
• US Population 33%
• Response-outcome 33%
• Mode of Delivery 33%
• Anti-IgE 33%
• Sublingual Immunotherapy 33%
• Allergic Asthma 33%
• Allergen 33%
• Allergen-specific 33%
• Omalizumab 33%
• Recombinant Allergen 33%
• Venom Allergy 33%
• Allergoid 33%
• Allergic Respiratory Diseases 33%
• T-cell Epitope 33%

Immunology and Microbiology

• Immunotherapy 100%
• Allergen 40%
• T Cell 20%
• Immune Response 20%
• Epitope 20%
• Agonist 20%
• Innate Immune System 20%
• Allergic Rhinitis 20%
• Allergen Immunotherapy 20%
• Allergic Asthma 20%
• Immunoglobulin E 20%
• Omalizumab 20%
• Recombinant Allergen 20%
• Sublingual Immunotherapy 20%
• Toll-Like Receptor 20%
• Peptides 20%